Creo Medical Group FY22 results and recent funding - Proactive Research Analyst
News release
by
Creo Medical Group PLC
Proactive Research Analyst John Savin gives the highlights from his latest research note on UK-based medical device company Creo Medical Group PLC (AIM:CREO). Savin talks about the company's recent performance and key products, before moving on to look at how it is positioned for the future. He also touches on a recent placing that generated a net £32 million.
Contact Details
Proactive UK Ltd
+44 20 7989 0813